To further determine whether altered expression of Bcl-xL influences the autophagy-related prognosis, we divided the ovarian carcinoma cases into low Bcl-xL expression (Bcl-xL−) and high Bcl-xL expression (Bcl-xL+) sets according to the cutpoint. The gene discussed is BCL2L1; the disease is ovarian carcinoma.